Our professionals
Dr. Ignacio Melero Bermejo
Co-Director of the Immunology and Immunotherapy Program.
Principal Investigator of the Combined Strategies in Translational Immunotherapy group.
Immunology Specialist
Primary focus on experimental cancer immunotherapy.
Professor of Immunology
Professional career
MD (1988) from the University of Navarra and PhD (1994), with Extraordinary Doctoral Award, from the Autonomous University of Madrid. He completed specialty training in Immunology at Hospital Universitario de la Princesa (Madrid, 1993). He worked for four years at the Bristol Myers Squibb research center in Seattle (USA).
Co-Director of the Department of Immunology and Immunotherapy since 2015.
Senior Researcher at the Center for Applied Medical Research (CIMA).
Professor of Immunology.
RESEARCH AREAS
- His research focuses on cancer immunology and immunotherapy, with a translational approach from experimental models to clinical trials.
- He has led more than 40 clinical trials as Principal Investigator.
- Senior Editor at Clinical Cancer Research, Scientific Editor at Cancer Discovery, Associate Editor at Frontiers in Immunology, and Section Editor at the Journal for Immunotherapy of Cancer (JITC). He also serves on the editorial boards of Immunotherapy, Autoimmunity, Oncoimmunology, Journal of Translational Medicine, World Journal of Immunology, Cancer Immunology Research, and Cancer Research.
- Member of the external advisory boards of Institut Curie (Paris), Gustave Roussy Institute, Granada Biomedical Research Institute, and the Netherlands Cancer Institute (NKI).
AREAS OF INTEREST
- Cancer immunology and immunotherapy
- Biological cancer therapy
- Clinical trials with monoclonal antibodies
- Cellular immunotherapy
- Gene therapy
Activity
In teaching
- Professor (Chair) at the School of Medicine, University of Navarra.
- Professor of Immunology by competitive examination since 2004.
- Director of the Expert Diploma in Immuno-Oncology at the School of Medicine, University of Navarra.
- He has delivered numerous lectures, courses, and seminars nationally and internationally.
In research
- He has authored more than 340 articles in international scientific journals.
- Author and co-author of 15 book chapters in his specialty.
- He has presented more than 175 communications at international conferences and 27 at national conferences.
Acknowledgements
In October 2022, invested doctor 'honoris causa' of the University of Buenos Aires.
In July 2020, Francisco Cobos Foundation Award in recognition of his scientific career.
In October 2018, appointed corresponding academic of the Royal National Academy of Medicine of Spain.
He has been awarded the prizes:
- Grand prize BIAL merit award in medical sciences 2004. Republic of Portugal.
- Conde de Cartagena Award 2006: (RANM).
- Grant Ortiz de Landazuri 2008
- Dr. Durantez Award Fundación LAIR 2011 and 2019. Endowed with 3.000€.
- European Academy of immunotherapy Life Career Award. (EATI 2016)
- CRI Lecture Award. Cancer Research Institute, New York, 2017.
- Corresponding member of The Royal Academy of Medicine (RANM). Spain. 2018
- EFIS Lecture Award: European Federation of Immunological Societies, Portugal. 2019
- Thesis director of Enrique Fuentes Quintana Awards for Doctoral Theses. 2019
- XVI Health Sciences. Fundación Caja Rural de Granada. 2020
- Highly Cited Researcher in the field of Cross-Field, Web of Science. 2020
- XIV Francisco Cobos Foundation Award. 2020
Scientific organizations
- Spanish Society of Immunology
- American Association of Immunologists
- American society of Gene Therapy
- Spanish Association of Gene Therapy
- American Association of Cancer Research